Likewise, in the peritonitis model, treatment with exogenous IFN-β enhanced efferocytosis assessed both in vivo and ex vivo and rescued hampered efferocytosis in Ifnb−/− macrophages (Supplementary Fig. 7a, b). The gene discussed is IFNB1; the disease is peritonitis.